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Reverse Transcripts: Implications for Pathogenesis and Transmission
Geethanjali Dornadula, Hui Zhang, Shubhra Shetty, and Roger J. Pomerantz1
The Dorrance H. Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine,
Jefferson Medical College, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, Pennsylvania 19107
Received July 29, 1998; returned to author for revision September 14, 1998; accepted October 9, 1998
It has been demonstrated that intravirion reverse transcription in human immunodeficiency virus type I (HIV-1) occurs in
the presence of physiological substances and that the intravirion HIV-1 reverse transcripts are important for the establish-
ment of infection in nondividing cells. In this report, we demonstrate that the infectivity of the virus produced from replicating
peripheral blood lymphocytes (PBL) is significantly higher than that of virions produced by nonproliferating macrophages,
upon infection of either initially quiescent PBLs or macrophages. This directly correlated with significantly higher intravirion
reverse transcripts in the virions from replicating PBLs, compared to those from macrophages. Treatment of replicating PBLs
and macrophages with 39- azido-39- deoxythymidine resulted in decreased intravirion reverse transcripts and lower infectivity
of produced virions, upon infection of initially quiescent T-cells or macrophages. Because both nonproliferating macrophages
and replicating lymphocytes are the major reservoirs for HIV-1 in vivo, we propose that as the result of higher levels of
intravirion reverse transcripts, the HIV-1 virions produced from actively replicating cells are more infectious than those from
nonproliferating cells. As such, this scenario implies at least one molecular mechanism for the intra- and interhost
transmission of HIV-1. © 1999 Academic Press


























Endogenous reverse transcription (RT) reactions are
mportant in evaluation of the kinetics and molecular
ntermediates of reverse transcription in various retrovi-
uses (Yong et al., 1990; Fuetterer and Hohn, 1987; Ba-
oonian et al., 1991). Reverse transcription of retrovi-
uses can occur within cell-free virions rather than only
fter infection of target cells (Zhang et al., 1993, 1994,
995a,b; Lori et al., 1992; Trono, 1992). Several studies
ave demonstrated that a significant level of endoge-
ous RT activity is found in human immunodeficiency
irus type I (HIV-1) without permeabilization (Zhang et al.,
993; Zhang et al., 1996a,b,c). Earlier, we reported that
eoxyribonucleoside triphosphates (dNTPs) enter into
IV-1 virions, without exogenous permeabilization of the
iral envelope, and DNA synthesis occurs to full-length
r nearly full-length (Zhang et al., 1996a). Similar results
ere obtained if murine leukemia virus was treated with
igh concentrations of dNTPs (Zhang et al., 1995a).
Intravirion HIV-1 DNA synthesis could occur in the
resence of several human physiological fluids, includ-
ng seminal and blood plasma. This phenomenon may
e due to endogenous dNTPs or physiological poly-
mines within these fluids. Intravirion HIV-1 DNA, which
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (215) 923-1956. E-mail: roger.j.pomerantz@mail.tju.edu.042-6822/99 $30.00
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10as increased by higher concentrations of dNTPs, also
ncreased viral infectivity in initially quiescent primary
uman T-lymphocytes but not in replicating T-lympho-
ytic cell lines (Zhang et al., 1996a). We reported that
mphipathic domains in the C-terminus of HIV-1 gp41
ay transverse the viral envelope leading to increased
ermeabilization to dNTPs and polyamines (Zhang et al.,
996c).
Of note, HIV-1 RT efficiency in primary human macro-
hages is significantly slower than in T-lymphoid cell
ines (O’Brien et al., 1994; Collin and Gordon, 1994). In
hese important studies, the investigators demonstrated,
y using quantitative polymerase chain reaction (PCR),
hat production of HIV-1 cDNA structures in macro-
hages required more than 36 h for full-length viral DNA
ynthesis, whereas H9 T-lymphocytic cells could com-
lete reverse transcription in 6–16 h after infection
O’Brien et al., 1994; Collin and Gordon, 1994). This is
hought to be due to low levels of free dNTPs in the
ytoplasm of macrophages (O’Brien et al., 1994; Meyer-
ans et al., 1994). Interestingly, hydroxyurea, which low-
rs intracellular dNTP levels, has also been demon-
trated to inhibit HIV-1 RT (Meyerhans et al., 1994; Gao et
l., 1993).
Virion-associated HIV-1 DNA synthesis is inhibited af-
er 39-azido-39-deoxythymidine (AZT) treatment of virus-
roducing cells (Zhang et al., 1996a). We have also de-






































































11INTRAVIRION HIV-1 DNAn blood plasma of HIV-1-infected individuals are altered
y treatment with nevirapine, a nonnucleoside analog
IV-1 RT inhibitor, and this phenomenon directly reflects
he efficiency and dynamics of the process of intravirion
everse transcription in vivo (Zhang et al., 1996b). Thus,
ntravirion HIV-1 DNA synthesis can take place in a
hysiological microenvironment and is termed “natural
ndogenous reverse transcription.” This process leads
o increased infectivity upon initially quiescent target
ells and may play a key role in HIV-1 transmission and
athogenesis (Zhang et al., 1996a,b). Interestingly, our
ecent data show that the viral core structure of the core
nvelope-linkage region disappears during the process
f intravirion reverse transcription, after incubating the
irus with dNTPs and polyamines, and indicates that
nitiation of reverse transcription occurs in this region of
he virion (manuscript submitted).
The major cellular reservoirs for HIV-1 in vivo have
een shown to be CD41 T-lymphocytes and macro-
hages (Spina et al., 1995; Bukrinsky et al., 1991). The
uccessful infection of nondividing macrophages or
angerhan cells in the mucosal regions may also be
mportant in sexual transmission of HIV-1 (Miller et al.,
992; Spira et al., 1996). Of note, the initiation of viral DNA
ynthesis is efficient in both mature macrophages and
uiescent T-lymphocytes, but the kinetics of elongation
s delayed (Zack et al., 1990, 1992). After the addition of
xogenous nucleosides to cell cultures, RT elongation is
ncreased in macrophages but not in quiescent T-lym-
hocytes, although this remains controversial (O’Brien et
l., 1994; Meyerhans et al., 1994). Thus, these data from
arious groups suggest that it is important to investigate
hether intravirion reverse transcripts play a role in
IV-1 replication in initially quiescent T-lymphocytes and
acrophages. In this report, we have analyzed the levels
f intravirion HIV-1 reverse transcripts in virions pro-
uced from replicating PBLs compared to those from
onproliferating macrophages and assessed the viral
nfectivity upon initially quiescent CD41 T-lymphocytes
nd nonproliferating macrophages.
RESULTS
ell-cycle analyses of proliferating (peripheral blood
ymphocytes) PBLs and nonreplicating macrophages
First, we evaluated replicating PBLs and nonreplicat-
ng macrophages via staining with propidium iodide and
ubsequent flow cytometric analysis. In Fig. 1, the peaks
epresent the percentage of cells in each stage of the
ell cycle for both PBLs and macrophages, individually.
he percentage of quiescent macrophages (G11G0) was
ore than 94%, as indicated in Fig. 1A. Of note, the
timulated PBLs demonstrated proportions of cells
hroughout the cell cycle (G11G0, 49%; S, 43.1%; G2, 7.9%)
Fig. 1B). Thus, these initial studies clearly demonstrated
hat the protocols we utilized led to primarily nonrepli-
ating macrophages and actively proliferating PBLs.ntravirion HIV-1 reverse transcripts are higher in the
irions produced from PBLs than those from
acrophages
The levels of intravirion reverse transcripts were esti-
ated in negative-strand strong-stop, gag, U3 regions,
nd plus-strand regions in the virions from replicating
BLs, as well as nonproliferating macrophages (Fig. 2).
fter producing virus from PBLs and macrophages, HIV-1
24 antigen levels were normalized and captured virions
ere utilized for DNA-PCR and RT-PCR assays. Of note,
irion RNA levels were used, in addition to HIV-1 p24
ntigen levels, to strictly normalize virion levels in each
reparation. The copy number of intravirion HIV-1 DNA
as relatively high in the RU5 region (strong-stop DNA)
FIG. 1. Cell-cycle analyses of PBLs and macrophages. Cells were
reated with 70% ethanol followed by RNase A in PBS. The cells were
hen stained with a solution containing propidium iodide, and analyzed
y fluorescence-activated cell sorting (Becton Dickinson). (A) Nonpro-




































































12 DORNADULA ET AL.nd then subsequently lower in U3, gag, and RU5-PBS-
NC regions, as described previously (Zhang et al.,
996a) (Fig. 2). The intravirion HIV-1 DNA levels in the
trong-stop negative-strand region (prior to the first tem-
late jump) were similar in virions from both PBLs and
acrophages. Of note, the U3, gag, and positive-strand
opy numbers of intravirion reverse transcripts were sig-
ificantly higher in viruses derived from PBLs than from
acrophages (Fig. 2 and Table 1).
Compared to the virions from untreated replicating
BLs, the virions from AZT-treated, replicating PBLs har-
ored significantly less intravirion reverse transcripts.
his decrease in intravirion reverse transcripts was also
oted in virions from AZT-treated macrophages, com-
ared to untreated macrophages. To determine the copy
umber per virion of intravirion HIV-1 DNA, RNA standard
urves were prepared, as described previously (Zhang et
l., 1994). A seperate aliquot of virion:bead complex was
sed. Viral RNA was extracted and subjected to RT-PCR
ith the HIV-1 gag primer/probe set and used for anal-
sis of specific cDNA copies of genomic viral RNA in
irions produced from each cell type, both with and
ithout AZT treatment (Fig. 2 and Table 1).
FIG. 2. Quantitative analysis of intravirion HIV-1 DNA and RNA levels
nti-gp120 and anti-gp41 antibody-coated latex beads (Abbott) from the
y DNase treatment. These isolated virions were utilized for DNA- and R
eft untreated. After extraction of RNA and DNA, the samples were subj
iral RNA was extracted and diluted at least 1:100-fold, reverse transcr
urves were generated using an in vitro transcribed gag RNA fragmen
Zhang et al., 1996a). The PCR products were analyzed by Southern blot
egative-strand DNA; (C) U3 DNA; (D) gag DNA; (E) plus-strand DNA
TABLE 1
Intravirion HIV-1 Reverse Transcripts
Virus-producing cells




eplicating PBL 2920 200 60 25
eplicating PBL 1 AZT 600 ,5 0 0
onproliferating
macrophage 2900 15 5 ,5
onproliferating
macrophage 1 AZT 800 0 0 0nfectivity of PBL-produced virus is greater than
acrophage-produced virus
To investigate the infectivity of HIV-1 virus from differ-
nt cells, we produced NL4-3balenv virus from replicat-
ng PBLs and macrophages and treated certain cultures
f virus-producing cells with 10 mM AZT, prior to harvest
f the supernatants. The viruses were placed onto a 20%
ucrose–TN solution and pelleted by centrifuging at
0,000 g for 1 h in a Ti60 rotor. The virions were resus-
ended in RPMI 1640 media and normalized by HIV-1
24 antigen levels. They were allowed to infect initially
uiescent PBLs and macrophages from HIV-1-seroneg-
tive individuals at 37°C for 4 h. As illustrated in Fig. 3,
nfectivity of HIV-1 virions produced by replicating PBLs
ere dramatically higher, when compared with the vi-
uses from macrophages, upon initially quiescent PBLs.
f importance, HIV-1 virions produced from replicating
BLs also were more infectious on target macrophages,
ompared to macrophage-produced virus. After AZT
reatment of replicating PBLs and macrophages, the in-
ectivity of virions produced from these cell cultures was
ecreased, and there was no significant difference in
nfectivity between those viruses produced from AZT-
reated macrophages, compared to those produced from
ZT-treated PBLs regardless of the target cell type (Fig.
). Of note, the levels of replication of HIV-1 virions from
ZT-treated PBLs, on either initially quiescent PBLs or
acrophages, were approximately the same as virions
roduced from macrophages which were not treated
ith AZT.
Because viral replication was higher in both macro-
hages and initially quiescent PBLs, with virions pro-
uced by replicating PBLs compared to macrophages, it
s unlikely that these effects are secondary to differences
n cellular proteins on the virion membranes. As well,
hese studies (Fig. 3) were reproducible using primary
BL- and macrophage-produced virus. HIV-1 virions were captured by
atants of replicating PBLs and nonproliferating macrophages, followed
. Of note, certain cell cultures were treated with AZT, while others were
o PCR with different primer/probe sets (Zhang et al., 1994, 1996a). The
o cDNA, and then amplified by PCR (Zhang et al., 1994). The standard
H-2 DNA (latently-infected line with one HIV-1 proviral copy per cell)
and quantitated with a PhosphorImager. (A) Viral RNA; (B) strong-stop






































13INTRAVIRION HIV-1 DNAells obtained from three separate individuals. No mixing
f different individuals’ cells was used in these studies
i.e., the same individuals’ cells were used as producers
nd targets).
irion uptake and internalization
To determine whether the viral infectivity differences
emonstrated above were due to differences in virion
inding and entry, HIV-1 p24 antigen uptake experiments
ere performed, as described previously (Zhang et al.,
996a) (Fig. 4). In brief, the virions produced by replicat-
ng PBLs and macrophages, approximately 100 ng of
FIG. 3. Comparison of infectivity of HIV-1 virions produced by PBLs an
he supernatants of proliferating PBLs and nonproliferating macrophag
ntigen levels, mixed with initially quiescent PBLs and macrophages
ostinfection and supernatants of each cell culture were harvested
xpression (ELISA; Dupont). These data were representative of three ind
quare, viruses from replicating PBLs without AZT treatment; diamo
acrophages without AZT treatment; and triangle, viruses from macro
FIG. 4. HIV-1 binding and internalization. One hundred nanograms o
ncubated with nonproliferating PBLs and macrophages for 4 h. The un
min. The cells were lysed and analyzed for intracellular HIV-1 p24 aIV-1 p24 antigen equivalents, were incubated with 107
nstimulated PBLs and macrophages at 37°C for 4 h.
he unbound virions were washed off with PBS, twice,
nd the residual bound virions were removed by incuba-
ion with 0.25% trypsin (Sigma) for 5 min at 37°C. The
rypsin reaction was stopped by washing with serum-
ontaining medium, and two more washings were per-
ormed with PBS. The cells were then analyzed by quan-
ifying intracellular HIV-1 p24 antigen by ELISA (Dupont),
fter cell lysis. Importantly, there were no significant
ifferences found in the internalization of HIV-1 virions in
arget cells, either PBLs or macrophages, regardless of
rophages, with or without AZT treatment. The NL4-3balenv virions from
her treated with AZT or left untreated, were normalized by HIV-1 p24
, and washed with PBS three times. PBLs were stimulated on day 3
icular time points. Viral growth was detected by HIV-1 p24 antigen
l separate experiments from three different HIV-1-seronegative donors.
ses from replicating PBLs with AZT treatment; circle, viruses from
with AZT treatment.
p24 antigen equivalents produced by PBLs and macrophages were
virions were washed off, and cells were further treated with trypsin for


















































































































14 DORNADULA ET AL.roducer cell type (Fig. 4). The viral capacity inside the
ell was low when compared to viral input, but HIV-1 p24
ntigen levels were approximately the same in both
arget quiescent PBLs and target macrophages, after
horough washings. Thus, increased binding and inter-
alization of virions was not involved in the increased
nfectivity of HIV-1 virions produced from replicating
BLs.
DISCUSSION
These studies demonstrate that intravirion reverse
ranscript levels differ in HIV-1 particles which are pro-
uced from nonreplicating human macrophages versus
ctively proliferating PBLs. Higher levels of intravirion
everse transcripts in HIV-1 virions produced from repli-
ating cells, compared to nonreplicating cells, may be
econdary to relatively higher levels of free dNTPs and
ossibly polyamines in these cells (Zhang et al., 1996a;
’Brien et al., 1994; Collin and Gordon, 1994). In addition,
he present studies demonstrate a direct and distinct
orrelation between virion infectivity and the cells which
roduce the virion particles.
We have previously shown that levels of intravirion
everse transcription can be altered without permeabi-
izing the lentivirion particles (Zhang et al., 1996a). As
uch, utilizing physiological substances at relevant con-
entrations, such as with dNTPs and polyamines, intra-
irion reverse transcription can be “driven” based on the
icroenvironment in which the virion particles are local-
zed (Zhang et al., 1996a). Our previous studies have
emonstrated that by stimulating intravirion reverse tran-
cription the infectivity of these lentiviral particles in-
reases in nonproliferating macrophages and initially
uiescent PBLs (Zhang et al., 1996a). This was also
learly demonstrated by other laboratories in nonrepli-
ating neurons in vivo (Naldini et al., 1996). It is important
o note that proliferating T-cells did not show a difference
n viral replication between intravirion HIV-1 reverse tran-
cription-stimulated virions and those lacking stimula-
ion of this process (Zhang et al., 1996a). This was also
emonstrated in the present studies, because there was
o difference in viral replication in actively replicating
BLs if virions from either macrophages or initially qui-
scent PBLs were used as a challenge stock (data not
llustrated). We have hypothesized that this was due to
he differences in intracellular microenvironments which
lter the potency of lentiviral reverse transcription after
nfection of these cells. Clearly, the intracellular environ-
ent of nonproliferating macrophages and quiescent
BLs is inhospitable for efficient HIV-1 reverse transcrip-
ion (Zhang et al., 1996a; O’Brien et al., 1994; Zack et al.,
990, 1992; Meyerhans et al., 1994). Thus, those virions
ith increased intravirion reverse transcripts would have
kinetic advantage in these cell types. This may be why
minority of virions containing increased intravirion re-
erse transcripts in a viral preparation can alter viraleplication in only inhospitable intracellular microenvi-
onments (see reference Zhang et al., 1996a).
The present studies extend these previous experi-
ents and show that the cell type which produces a
irion may alter the virion’s infectivity, based on the level
f intravirion HIV-1 DNA contained in the produced par-
icles. The same subject’s primary cells in an individual
xperiment were used for both the viral-producing PBLs
nd macrophages, as well as the PBLs and macro-
hages used as targets. In this manner, we sought to
void interactions between virions produced from cells
f differing individuals than those cells used as targets.
ecent data have demonstrated that HIV-1 virions con-
ain cellular proteins on their surface and, thus, this
ight be a confounding series of variables if different
onors were mixed in each of these separate experi-
ents (Fortin et al., 1997; Arthur et al., 1992). As well, we
epeated these studies in three different HIV-1-seroneg-
tive donors to further verify the major findings in these
tudies, namely that virions from proliferating PBLs are
ore infectious for both initially quiescent PBLs and
acrophages as cell targets.
It remains formally possible that cellular proteins in-
orporated into virions might also have increased the
nfectivity of viruses produced from one cell type, when
argeted to the same cell type (Fortin et al., 1997; Arthur
t al., 1992). Of note, if this occurred, it did not signifi-
antly alter the effects of intravirion reverse transcription
hich was the leading correlate for increased virion
nfectivity, whether the same or a different target cell,
ompared to the producing cell type, was utilized. As
oted above, the lack of differences in binding and in-
ernalization studies strongly points against cellular pro-
ein interactions as a primary cause leading to these
indings. Nevertheless, other alterations in the “reverse
ranscription machinery” of HIV-1 may also occur, with
ncreased intravirion reverse transcripts as a marker for
hese primary virion changes.
Our laboratories have demonstrated that intravirion
everse transcription also alters simian immunodefi-
iency virus (SIV) infectivity (Dornadula et al., 1997). In
ecent studies these initial findings were extended in an
n vivo macaque model system. Intravenous infection of
onkeys with SIV virion preparations, in which intravirion
everse transcription was stimulated, led to increased
iral replication and longer time periods of detectable
irus in the bloodstream of macaques, compared to ma-
aques infected with normalized virion preparations in
hich intravirion reverse transcription was not stimu-
ated (manuscript submitted). Thus, intravirion reverse
ranscription may be critical in altering viral infectivity
evels in primate lentiviruses and may also be important
n molecular mechanisms involved with vertical and/or
orizontal transmission of primate lentiviruses.
The present studies suggest that HIV-1 virions from
ctively replicating CD41 T-lymphocytes may have in-





































































































15INTRAVIRION HIV-1 DNAompared to virions produced from nonreplicating, tis-
ue-bound macrophages. Of note, the precise cells in-
ected in the female genital tract by primate lentiviruses
emain somewhat controversial (Miller et al., 1992, 1998;
pira et al., 1996). As such, further studies will be useful
n further determining the in vivo importance of these




The envelope (env) gene of the T-cell-line-tropic
CXCR-4-tropic) HIV-1 strain, NL4-3, was replaced with
hat of the macrophage-tropic (CCR5-tropic) HIV-1 Bal
train by removing a SalI–BamHI fragment of the R8 Bal
lasmid (kindly provided by Dr. D. Trono, University of
eneva) and placing it in the same site in NL4-3. The
ew plasmid was sequence-confirmed and titled pNL4-
balenv, which now had macrophage-tropic properties.
o generate a viral stock, 10 mg of pNL4-3balenv plasmid
NA was transfected into RD (rabdomyosarcoma) cells
y calcium phosphate precipitation (Zhang et al., 1995a).
he supernatant was harvested on day 5 and stored in
liquots at 270°C.
ells and production of HIV-1 virions
Peripheral blood mononuclear cells were derived from
ealthy, HIV-1-seronegative normal donors by Ficoll gra-
ient centrifugation. The isolated PBMCs were placed
nto 2% gelatin-coated flasks to isolate monocyte/mac-
ophages (Collman et al., 1989). The unattached PBLs
ere washed with phosphate-buffered saline (PBS)
wice and cultured for 48 h, in either the presence or the
bsence of purified phytohemagglutinin (PHA) (Sigma)
10 mg/ml) and 50 units of natural human interleukin II
IL-2; BRL-GIBCO). The attached monocyte/macro-
hages were resuspended with 5 mM EDTA and cultured
n a mixture of 10% fetal calf serum (FCS), 10% horse
erum, and 0.1 mM nonessential amino acids (NEAA)
GIBCO) for 14 days, as described previously (Collman et
l., 1989). The replicating PBLs and nonreplicating mac-
ophages were then infected with the NL4-3balenv stock
irus. The unbound virions were washed off vigorously
ith PBS. After 5 days, the supernatants harboring prog-
ny viruses were collected and frozen at 270°C. As
ontrols, specific cultures of PBLs and macrophages
ere treated with 10 mM of AZT (Sigma) and allowed to
row for a further 3 days. The supernatants were col-
ected and passed through a 20% sucrose cushion to
emove the AZT. Control virion-containing supernatants
without AZT) were also passed through a 20% sucrose
ushion at the same time. Then, the virion preparations
ere normalized by quantitating for HIV-1 p24 antigen via
nzyme-linked immunosorbant assays (ELISA; Dupont)
nd used in infectivity assays. All experiments wereerformed in primary cells from HIV-1-seronegative indi-
iduals and repeated using three different individuals’
ells, in independent studies.
ell-cycle analyses
To estimate the percentage of replicating PBLs and
onproliferating macrophages in each stage of the cell
ycle, the cells were prepared for fluorescence-activated
ell sorting analysis. Briefly, 0.5 3 106 cells were mixed
ently with 70% ethanol and incubated on ice for 10 min.
hen, the cells were concentrated and resuspended in
00 ml of RNase A (180 mg/ml) and incubated for 30 min
t room temperature. After addition of 200 ml of pro-
idium iodide (50 mg/ml; Sigma), the cells were incu-
ated for 15 min at room temperature and analyzed by
low cytometry (Becton Dickinson).
ntravirion HIV-1 reverse transcripts
For analysis of intravirion reverse transcripts, the viri-
ns were isolated by an immunocapture methodology.
IV-1 virions produced from AZT-treated or nontreated
ells were captured by anti-gp120 and anti-gp41 coated
eads (Abbott, Inc.) from the supernatants of replicating
BLs and nonreplicating macrophages producing virus.
fter DNase treatment, as described previously (Zhang
t al., 1994), quantitative DNA- and RT-PCR were per-
ormed. The RU5 region (negative-strand, strong-stop
NA) was detected with primer/probe set, M667-AA55/
K31; the gag region was detected by primer/probe set,
K38-SK39/SK19. The U3 region was detected by the
rimer pair U31-U32/probe U33, and the RU5-primer
inding site-59 noncoding region (5NC), which amplifies
early full-length reverse transcripts, was detected by
he primer/probe set, M667-M661/SK31 (Zhang et al.,
994). The PCR products were analyzed by standard
outhern blotting. The 32P-labeled blots were analyzed
nd quantitated with a PhosphorImager (Molecular Dy-
amics, Sunnyvale, CA) and copy numbers were calcu-
ated by comparison with standard curves (Zhang et al.,
994). RT-PCR for HIV-1 RNA in virions was performed
sing the gag primer and probe set, as described previ-
usly (Zhang et al., 1994).
iral infectivity
The viral infectivity assays were performed with vi-
uses produced from stimulated PBLs and macrophages,
y incubation with initially unstimulated PBLs and mac-
ophages at 37°C for 4 h. The input of virions was strictly
ormalized in all infections (500 pg of HIV-1 p24 antigen).
he unbound virions were washed off with PBS, three
imes, and PBLs were cultured in RPMI 1640 medium
lus 10% FCS and the macrophages were cultured in
ulbecco’s modified Eagle’s medium plus 10% FCS, 10%
orse serum, and 0.1 mm NEAA. After overnight incuba-
ion, supernatants were collected on day 0 for HIV-1 p24









































16 DORNADULA ET AL.ion, PHA (5 mg/ml; Sigma) and natural human IL-2 (50
/ml; BRL-GIBCO) were added to the PBL cultures. On
he fifth day, PHA and IL-2 were washed off by pelleting
he infected cells via centrifugation. The PBLs were then
ultured with IL-2 (10 U/ml) only. Samples of the super-
atants (0.5 ml each) were collected at specified time
oints. The HIV-1 p24 antigen levels were quantitated by
LISA. Of importance, the same individuals’ cells were
sed to produce virions and as target cells.
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